ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ — ImmunoForge announced that it…

DJI Launches All-in-One Vlog Camera Drone with DJI Flip

New DJI Flip is DJI’s first drone to feature foldable, full-coverage propeller…

Triller Downloads Skyrocket Ahead of TikTok Ban

LOS ANGELES, Jan. 14, 2025 /PRNewswire/ — Triller, a creator-focused social media…

RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility

Powered by Android 14 and Qualcomm® Snapdragon™ 6490 Octa-Core Processor, Engineered for…

Cognex Strengthens Market Leadership in Industrial Barcode Reading with Two New AI-Powered Products

DataMan 290 and 390 barcode readers, backed by industry-leading customer support, deliver…

IFF Pharma Solutions Wins Pharmaceutical Technology Excellence Award

Recognized for brand leadership with its "Timing is Everything" controlled release platform…

MINISO Group Announces Completion of US$550 Million Equity Linked Securities

GUANGZHOU, China, Jan. 14, 2025 /PRNewswire/ — MINISO Group Holding Limited (NYSE:…

Bybit Card Partners with Entravel to Bring Discounted Luxury Travel to Its Users

DUBAI, UAE, Jan. 14, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency…